Keyphrases
Analytical Performance
20%
Androgens
18%
Antiphospholipid Antibodies
18%
Antiphospholipid Syndrome
21%
Autoantibodies
49%
Binding Properties
16%
C-terminal Agrin Fragment
32%
Cardiolipin
15%
Central Laboratory
33%
Chemiluminescent Enzyme Immunoassay (CLEIA)
34%
Clinical Application
26%
Clinical Chemistry
21%
Clinical Laboratory
17%
Clinically Significant
17%
Coproporphyrin
23%
Dehydroepiandrosterone Sulfate (DHEAS)
19%
Depressed Patients
19%
Elecsys
22%
External Quality Assessment
35%
Fetuin-A
18%
Germany
33%
Glycoprotein
26%
Hemoglobin A1c (HbA1c)
16%
Immunoassay
51%
Immunosensor
20%
Ketoconazole
16%
Kidney Function
16%
Laboratory Diagnosis
23%
Liquid Chromatography-tandem Mass Spectrometry (LC-MS/MS)
20%
Menopausal Transition
16%
Monoclonal Antibody
23%
Multicentre Evaluation
17%
Near-patient
21%
Perimenopausal
15%
Perimenopause
22%
Point-of-care
46%
Point-of-care Testing
100%
Polycystic Ovary Syndrome
17%
Postmenopausal Women
16%
Preanalytical Phase
18%
Quality Assurance
20%
Serum Concentration
30%
Serum Levels
21%
Sex Hormone-binding Globulin
57%
Surface Plasmon Resonance Sensor
29%
Testosterone
39%
Therapeutic Drug Monitoring
22%
Toll-like
17%
Type 1 Diabetes Mellitus (T1DM)
20%
β2-glycoprotein I (β2GPI)
28%
Medicine and Dentistry
Agrin
10%
Albumin
12%
Alkaline Phosphatase
10%
Androgen
15%
Antiphospholipid Antibody
10%
Autoantibodies
8%
Biological Marker
8%
Blood Gas
12%
Blood Gas Analysis
13%
Blood Glucose
20%
Bone Density
17%
Bone Remodeling
13%
Cancellous Bone
8%
Carboxy Terminal Sequence
11%
Cardiolipin
10%
Chronic Kidney Disease
10%
Climacterium
28%
Diabetes
12%
Diabetes Mellitus
18%
Diagnostic Performance
7%
Disease
12%
Diseases
8%
Emergency Department
8%
Emergency Medicine
8%
Fetuin A
12%
First Trimester Pregnancy
10%
Glycoprotein
11%
Health Care Cost
20%
Hemoglobin A1c
12%
Hyperandrogenism
7%
Intensive Care Unit
12%
Kidney Function
15%
Laboratory Medicine
15%
Laboratory Test
12%
Ossification
9%
Osteocalcin
10%
Osteolysis
21%
Ovulation
7%
Point-of-Care Testing
74%
Postmenopause
16%
Postoperative Complication
9%
Premenopause
12%
Progesterone
7%
Prospective Study
8%
Pyridinoline
8%
Secondary Amenorrhea
10%
Sex Hormone Binding Globulin
24%
Surface Enhanced Raman Spectroscopy
10%
Surgical Risk
7%
Therapeutic Drug Monitoring
7%
